Literature DB >> 25323490

[Reflux and hiatus hernia in the controversy between conservative and operative therapy].

S M Freys1, J Heimbucher.   

Abstract

Approximately 20 % of the population are affected by gastroesophageal reflux disease (GERD). The subjective clinical and objective pathological extent of the disease is highly variable and the underlying pathophysiological mechanisms extraordinarily diverse. The importance of hiatus hernia for GERD has been intensively debated for decades. Hiatus hernia was initially considered to be at the center of the pathophysiology but later the function of the lower esophageal sphincter was increasingly considered to be of importance. Currently, additional relevant pathophysiological cofactors are being detected with the continuous improvement in diagnostic methods and used for therapeutic decision-making. Despite standardization of the operative technique and increasing criticism on long-term proton pump inhibitor (PPI) therapy, antireflux surgery still requires a very critical assessment of indications based on a comprehensive diagnostic evaluation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25323490     DOI: 10.1007/s00104-014-2804-0

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  27 in total

1.  Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication.

Authors:  G M Campos; J H Peters; T R DeMeester; S Oberg; P F Crookes; S Tan; S R DeMeester; J A Hagen; C G Bremner
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

2.  [A simple operation for control of reflux esophagitis].

Authors:  R NISSEN
Journal:  Schweiz Med Wochenschr       Date:  1956-05-18

3.  Gastro-oesophageal reflux disease: beyond proton pump inhibitor therapy.

Authors:  Tiberiu Hershcovici; Ronnie Fass
Journal:  Drugs       Date:  2011-12-24       Impact factor: 9.546

4.  Reflux esophagitis, sliding hiatal hernia, and the anatomy of repair.

Authors:  P R ALLISON
Journal:  Surg Gynecol Obstet       Date:  1951-04

5.  EAES recommendations for the management of gastroesophageal reflux disease.

Authors:  Karl Hermann Fuchs; Benjamin Babic; Wolfram Breithaupt; Bernard Dallemagne; Abe Fingerhut; Edgar Furnee; Frank Granderath; Peter Horvath; Peter Kardos; Rudolph Pointner; Edoardo Savarino; Maud Van Herwaarden-Lindeboom; Giovanni Zaninotto
Journal:  Surg Endosc       Date:  2014-05-02       Impact factor: 4.584

Review 6.  [Newly recognized side-effects of proton pump inhibitors. Arguments in favour of fundoplication for GERD?].

Authors:  B H A von Rahden; M Scheurlen; J Filser; H J Stein; C-T Germer
Journal:  Chirurg       Date:  2012-01       Impact factor: 0.955

7.  Role of the lower esophageal sphincter and hiatal hernia in the pathogenesis of gastroesophageal reflux disease.

Authors:  M Fein; M P Ritter; T R DeMeester; S Oberg; J H Peters; J A Hagen; C G Bremner
Journal:  J Gastrointest Surg       Date:  1999 Jul-Aug       Impact factor: 3.452

Review 8.  [Antireflux operations: indications and techniques].

Authors:  H Feussner; D Wilhelm
Journal:  Chirurg       Date:  2013-04       Impact factor: 0.955

9.  Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease using multiple Plicator implants: 12-month multicenter study results.

Authors:  D von Renteln; I Schiefke; K H Fuchs; S Raczynski; M Philipper; W Breithaupt; K Caca; H Neuhaus
Journal:  Surg Endosc       Date:  2009-05-14       Impact factor: 4.584

Review 10.  New and future drug development for gastroesophageal reflux disease.

Authors:  Carla Maradey-Romero; Ronnie Fass
Journal:  J Neurogastroenterol Motil       Date:  2013-12-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.